Browsing by Author Fonseca, R.

Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
20-Jun-2013A Novel Measure of Chromosome Instability Can Account for Prognostic Difference in Multiple MyelomaChung, T.-H. ; Mulligan, G.; Fonseca, R.; Chng, W.J.
Oct-2009Centrosomes and myeloma; aneuploidy and proliferationChng, W.J. ; Fonseca, R.
Jun-2011Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myelomaChng, W.-J.; Huang, G.F. ; Chung, T.H. ; Ng, S.B.; Gonzalez-Paz, N.; Troska-Price, T.; Mulligan, G.; Chesi, M.; Bergsagel, P.L.; Fonseca, R.
2008Clinical and biological significance of RAS mutations in multiple myelomaChng, W.J. ; Van, Wier S.; Fonseca, R.; Gonzalez-Paz, N.; Price-Troska, T.; Rajkumar, S.V.; Kyle, R.A.; Henderson, K.J.; Greipp, P.; Jacobus, S.; Oken, M.M.; Van, Ness B.
2010Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: Identification of 1p31-32 deletion as a prognostic factor in myelomaChng, W.J. ; Van, Wier S.; Keats, J.J.; Bergsagel, P.L.; Fonseca, R.; Gertz, M.A.; Chung, T.-H. ; Baker, A.; Carpten, J.
May-2012Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalitiesBraggio, E.; Dogan, A.; Keats, J.J.; Chng, W.J.; Huang, G. ; Matthews, J.M.; Maurer, M.J.; Law, M.E.; Bosler, D.S.; Barrett, M.; Lossos, I.S.; Witzig, T.E.; Fonseca, R.
Feb-2014IMWG consensus on risk stratification in multiple myelomaChng, W.J. ; Dispenzieri, A.; Chim, C.-S.; Fonseca, R.; Goldschmidt, H.; Lentzsch, S.; Munshi, N.; Palumbo, A.; Miguel, J.S.; Sonneveld, P.; Cavo, M.; Usmani, S.; Durie, B.G.; Avet-Loiseau, H.
Aug-2013Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalitiesJimenez-Zepeda, V.H.; Chng, W.J. ; Schop, R.F.J.; Braggio, E.; Leis, J.F.; Kay, N.; Fonseca, R.
2008The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibitionChng, W.J. ; Braggio, E.; Fonseca, R.; Mulligan, G.; Bryant, B.; Remstein, E.; Dogan, A.; Valdez, R.